BRWA
BIIB icon

B. Riley Wealth Advisors’s Biogen BIIB Stock Holding History

B. Riley Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$454K Buy
2,094
+30
+1% +$5.74K 0.02% 499
2026
Q1 		$387K Buy
2,064
+68
+3% +$12.5K 0.02% 507
2025
Q4 		$351K Sell
1,996
-30
-1% -$4.9K 0.02% 647
2025
Q3 		$284K Buy
2,026
+35
+2% +$4.73K 0.01% 746
2025
Q2 		$250K Buy
+1,991
New +$248K 0.01% 787
2024
Q4 		$358K Buy
2,343
+92
+4% +$15.5K 0.01% 803
2024
Q3 		$425K Sell
2,251
-330
-13% -$69K 0.01% 805
2024
Q2 		$598K Sell
2,581
-894
-26% -$194K 0.02% 734
2024
Q1 		$893K Buy
3,475
+97
+3% +$22.7K 0.02% 559
2023
Q4 		$874K Sell
3,378
-97
-3% -$23.8K 0.02% 576
2023
Q3 		$893K Sell
3,475
-347
-9% -$92.8K 0.02% 559
2023
Q2 		$1.09M Sell
3,822
-292
-7% -$86.9K 0.02% 540
2023
Q1 		$1.14M Sell
4,114
-737
-15% -$204K 0.03% 503
2022
Q4 		$1.34M Buy
4,851
+604
+14% +$171K 0.04% 445
2022
Q3 		$1.14M Buy
4,247
+3
+0.1% +$637 0.03% 470
2022
Q2 		$866K Sell
4,244
-565
-12% -$116K 0.04% 465
2022
Q1 		$1.01M Sell
4,809
-465
-9% -$101K 0.03% 481
2021
Q4 		$1.27M Sell
5,274
-490
-9% -$126K 0.04% 459
2021
Q3 		$1.66M Sell
5,764
-267
-4% -$87.5K 0.05% 388
2021
Q2 		$2.05M Sell
6,031
-1,002
-14% -$304K 0.07% 327
2021
Q1 		$1.95M Buy
7,033
+1,361
+24% +$367K 0.07% 309
2020
Q4 		$1.39M Sell
5,672
-699
-11% -$180K 0.07% 259
2020
Q3 		$1.79M Buy
6,371
+514
+9% +$143K 0.1% 215
2020
Q2 		$1.57M Sell
5,857
-885
-13% -$266K 0.1% 200
2020
Q1 		$2.13M Buy
6,742
+2,538
+60% +$770K 0.18% 132
2019
Q4 		$1.25M Buy
4,204
+1,354
+48% +$376K 0.11% 206
2019
Q3 		$664K Buy
2,850
+683
+32% +$159K 0.07% 313
2019
Q2 		$507K Sell
2,167
-980
-31% -$226K 0.06% 371
2019
Q1 		$745K Buy
3,147
+1,135
+56% +$357K 0.09% 240
2018
Q4 		$607K Buy
2,012
+113
+6% +$36.1K 0.09% 249
2018
Q3 		$672K Buy
1,899
+1,038
+121% +$357K 0.08% 271
2018
Q2 		$250K Sell
861
-223
-21% -$62.7K 0.03% 535
2018
Q1 		$298K Sell
1,084
-145
-12% -$45K 0.04% 459
2017
Q4 		$393K Sell
1,229
-169
-12% -$54.2K 0.05% 369
2017
Q3 		$438K Sell
1,398
-381
-21% -$113K 0.07% 290
2017
Q2 		$483K Sell
1,779
-9
-0.5% -$2.38K 0.09% 259
2017
Q1 		$490K Buy
1,788
+225
+14% +$63.6K 0.1% 237
2016
Q4 		$444K Sell
1,563
-934
-37% -$277K 0.09% 251
2016
Q3 		$782K Buy
2,497
+310
+14% +$91.8K 0.15% 171
2016
Q2 		$530K Sell
2,187
-745
-25% -$196K 0.11% 238
2016
Q1 		$763K Sell
2,932
-192
-6% -$50.7K 0.18% 142
2015
Q4 		$958K Buy
3,124
+618
+25% +$178K 0.19% 137
2015
Q3 		$733K Buy
2,506
+234
+10% +$77.3K 0.18% 153
2015
Q2 		$920K Sell
2,272
-36
-2% -$14.4K 0.23% 115
2015
Q1 		$975K Sell
2,308
-1,070
-32% -$422K 0.24% 108
2014
Q4 		$6.39K Buy
3,378
+1,789
+113% +$579K 0.14% 179
2014
Q3 		$526K Sell
1,589
-1,285
-45% -$424K 0.14% 198
2014
Q2 		$413K Buy
2,874
+1,321
+85% +$398K 0.1% 230
2014
Q1 		$475K Buy
+1,553
New +$493K 0.14% 162
2013
Q3 		– Sell
-1,023
Closed -$220K – 671
2013
Q2 		$220K Buy
+1,023
New +$219K 0.07% 293

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
NGM
North Growth Management Vancouver, British Columbia, Canada $780M AUM 102.77% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return

B. Riley Wealth Advisors's BIIB Position: Q2 2026 in Review

B. Riley Wealth Advisors increased its Biogen (BIIB) stake by 1.5% in Q2 2026, buying an estimated $5.74K and bringing the position to 2,094 shares worth $454K. The position accounts for 0.02% of the portfolio, ranked #499.

B. Riley Wealth Advisors first reported a position in BIIB in Q2 2013 and has held it in 50 quarters since. The position peaked at $2.13M in Q1 2020. 199 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • B. Riley Wealth Advisors held 2,094 shares of Biogen worth $454K as of Q2 2026.
  • B. Riley Wealth Advisors bought 30 Biogen shares in Q2 2026, an estimated $5.74K.
  • Biogen made up 0.02% of B. Riley Wealth Advisors's portfolio in Q2 2026, its #499 holding.
  • B. Riley Wealth Advisors first reported a position in Biogen in Q2 2013 and has held it in 50 quarters since.
  • B. Riley Wealth Advisors's Biogen position peaked at $2.13M in Q1 2020.
  • 199 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.